PeptiStar aspires to enhance patients’ QOL, not only in Japan, but around the globe, by garnering high level development and manufacturing technologies developed by top level companies in Japan. This spirit is what drives PeptiStar’s ability to continuously deliver novel innovation. Our mission is to deliver highly cost competitive, high-quality Peptide and Oligonucleotide APIs and to this end, we continuously strive to hone our skills to fulfill the responsibility as the largest class leading CDMO in Asia.
